Advances in drug delivery for articular cartilage
- 7 December 2002
- journal article
- review article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 86 (1), 1-14
- https://doi.org/10.1016/s0168-3659(02)00373-5
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Porcine mesenchymal stem cellsCell and tissue research, 2002
- Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destructionArthritis & Rheumatism, 2002
- IGF-I and Mechanical Environment Interact to Modulate Engineered Cartilage DevelopmentBiochemical and Biophysical Research Communications, 2001
- Effects of fibronectin on articular cartilage chondrocyte proteoglycan synthesis and response to insulin‐like growth factor‐IJournal of Orthopaedic Research, 1998
- THE ROLE OF IL-4 AND IL-6 IN IL-1-DEPENDENT CARTILAGE MATRIX DEGRADATIONRheumatology, 1995
- Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells.The Journal of cell biology, 1993
- A synthetic peptide metalloproteinase inhibitor, but not Timp, prevents the breakdown of proteoglycan within articular cartilagein vitroInflammation Research, 1992
- Differential effects of transforming growth factor‐β and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytesJournal of Cellular Physiology, 1990
- Stimulation of cartilage‐matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor‐betaJournal of Cellular Physiology, 1989
- Modulation of Chondroblast Phenotype by Transforming Growth Factor-BetaPathology and Immunopathology Research, 1988